Evidence map›Paper›PMID 41065754›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2025

Cytokine-Induced Barrier Dysfunction and Lipid Signaling in a Gut-On-Chip Model.

Moran Morelli, Mariyana V Savova, Karla Queiroz, Amy C Harms, Thomas Hankemeier

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Cytokine-Induced Barrier Dysfunction and Lipid Signaling in a Gut-On-Chip Model.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Moran MorelliMimetas, Oegstgeest, the Netherlands.ORCID https://orcid.org/0000-0003-0262-7221
Mariyana V SavovaMetabolomics and Analytics Center, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands.ORCID https://orcid.org/0000-0001-6840-6056
Karla QueirozMimetas, Oegstgeest, the Netherlands.ORCID https://orcid.org/0000-0002-5205-5682
Amy C HarmsMetabolomics and Analytics Center, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands.ORCID https://orcid.org/0000-0002-2931-4295
Thomas HankemeierMetabolomics and Analytics Center, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands.ORCID https://orcid.org/0000-0001-7871-2073

Funding

EC | Horizon 2020 Framework Programme (H2020) 812969Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) 16490Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) 184.034.019Oncode Institute NGFOP2201
6 · The paper itself

Abstract

The intestinal epithelial barrier is crucial for gut homeostasis, with dysfunction linked to inflammatory disorders like inflammatory bowel disease (IBD). While cytokines are established mediators of barrier disruption, the role of lipid signaling remains poorly understood. Using a microfluidic platform, we cultured epithelial tubules and exposed their luminal (apical) side to TNF-α, IL-1β, and IFN-γ (0-200 ng/mL) under serum-containing or serum-free conditions. Barrier function was assessed primarily via transepithelial electrical resistance (TEER), with DRAQ7 staining and actin cytoskeletal analysis providing complementary indicators of membrane integrity and structural disruption. In parallel, a targeted liquid chromatography-tandem mass spectrometry approach was used to profile lipid mediators across apical and basolateral compartments. Cytokine exposure significantly impaired barrier integrity, as indicated by reduced TEER, alongside associated cell damage and structural changes reflected by DRAQ7 staining and actin remodeling. The remodeling effect was lower in serum-free medium. Lipid profiling revealed inflammatory signatures characterized by an increase in prostaglandins in the luminal compartment, particularly under serum-free conditions. PGF1α increased under both media conditions, whereas the rest of the changes were condition-specific, with a rise in PGE1, PGE2, and PGD2, among others, particularly under serum-free conditions. Simultaneously, changes in other eicosanoids, but not in prostaglandins, were detected in the basolateral compartment under serum-free conditions. This proof-of-principle study demonstrates how medium composition significantly influences inflammatory responses and lipid signaling patterns in a physiologically relevant gut-on-chip model. Our integrated approach reveals the complex spatial organization of lipid mediators during cytokine-induced barrier dysfunction and provides a valuable framework for investigating the interplay between inflammation, barrier integrity, and lipid metabolism in intestinal pathophysiology.

Indexed as

CytokinesIntestinal MucosaLipid MetabolismSignal TransductionCaco-2 CellsHumansInflammatory Bowel DiseasesLab-On-A-Chip DevicesCytokinescytokinesgut permeabilityinflammationintestinal integrityintestine‐on‐chipserumsignaling lipids

Identifiers

PMID41065754
PMCPMC12510296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.